Loading...
XSTO
AINO
Market cap3mUSD
May 05, Last price  
0.19SEK
1D
0.54%
1Q
-8.87%
Jan 2017
-99.25%
IPO
-99.11%
Name

Aino Health AB (publ)

Chart & Performance

D1W1MN
No data to show
P/E
—
P/S
1.58
EPS
—
Div Yield, %
—
Shrs. gr., 5y
54.88%
Rev. gr., 5y
-1.54%
Revenues
24m
+0.09%
17,496,00022,252,0005,532,00019,252,00020,754,00025,873,00024,916,00023,044,00019,908,00023,919,00023,941,000
Net income
-10m
L-7.00%
-913,0001,463,000-5,991,000-31,790,000-22,006,000-15,276,000-12,771,000-16,522,000-15,367,000-10,661,000-9,915,000
CFO
-5m
L-27.36%
-1,171,000198,000-3,001,000-25,887,000-16,269,000-10,776,000-12,069,000-8,113,000-12,873,000-6,261,000-4,548,000
Earnings
May 12, 2025

Profile

Aino Health AB (publ) provides corporate health management solutions for private and public organizations in Finland. It offers HealthManager, a software as a service solution that provides surveys, analytics, exposure checks, and security and GDPR services; and e-learning platform. The company also provides telemedicine services; professional services, including analytics, management and employee support, and well-being services; onboarding services, such as project management and planning, implementation, and training and communication services; and other services to occupational health care providers, insurance companies, IT software and service companies, HR, payroll service centers, nurses, online therapists, etc. Aino Health AB (publ) is based in Stockholm, Sweden.
URL
https://ainohealth.com/
IPO date
Dec 16, 2016
Employees
22
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
23,941
0.09%
23,919
20.15%
19,908
-13.61%
Cost of revenue
2,434
21,084
3,099
Unusual Expense (Income)
NOPBT
21,507
2,835
16,809
NOPBT Margin
89.83%
11.85%
84.43%
Operating Taxes
405
Tax Rate
2.41%
NOPAT
21,507
2,835
16,404
Net income
(9,915)
-7.00%
(10,661)
-30.62%
(15,367)
-6.99%
Dividends
Dividend yield
Proceeds from repurchase of equity
3,081
10,000
BB yield
-5.97%
-11.85%
Debt
Debt current
Long-term debt
164
659
Deferred revenue
Other long-term liabilities
(659)
Net debt
(741)
(1,271)
(1,544)
Cash flow
Cash from operating activities
(4,548)
(6,261)
(12,873)
CAPEX
Cash from investing activities
1,322
Cash from financing activities
3,820
5,572
13,193
FCF
18,497
(282)
18,726
Balance
Cash
741
1,435
2,158
Long term investments
45
Excess cash
239
1,208
Stockholders' equity
3,851
(87,004)
(14,166)
Invested Capital
(458)
86,317
12,591
ROIC
50.10%
5.73%
106.03%
ROCE
EV
Common stock shares outstanding
187,710
125,791
47,275
Price
0.24
-41.46%
0.41
-77.03%
1.79
132.42%
Market cap
45,050
-12.65%
51,574
-38.88%
84,386
257.05%
EV
44,309
50,303
160,734
EBITDA
21,507
5,835
19,683
EV/EBITDA
2.06
8.62
8.17
Interest
1,095
796
Interest/NOPBT
38.62%
4.74%